Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans

Receptor Binding and Membrane Fusion in Virus Entry: The Influenza Hemagglutinin

Skehel, J. J., & Wiley, D. C. (2000) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.69.1.531 · Cited by 2,706

Antibody Recognition of a Highly Conserved Influenza Virus Epitope

Ekiert, D. C., Bhabha, G., Elsliger, M.-A., Friesen, R. H. E., Jongeneelen, M., Throsby, M., Goudsmit, J., & Wilson, I. A. (2009) · Science · doi:10.1126/science.1171491 · Cited by 1,326

Cross-Reactive Antibody Responses to the 2009 Pandemic H1N1 Influenza Virus

Hancock, K., Veguilla, V., Lu, X., Zhong, W., Butler, E. N., Sun, H., Liu, F., Dong, L., DeVos, J. R., Gargiullo, P. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0906453 · Cited by 1,260

Humoral Immunity Due to Long-Lived Plasma Cells

Slifka, M. K., Antia, R., Whitmire, J. K., & Ahmed, R. (1998) · Immunity · doi:10.1016/s1074-7613(00)80541-5 · Cited by 1,249

A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A Hemagglutinins

Corti, D., Voss, J., Gamblin, S. J., Codoni, G., Macagno, A., Jarrossay, D., Vachieri, S. G., Pinna, D., Minola, A., Vanzetta, F., et al. (2011) · Science · doi:10.1126/science.1205669 · Cited by 1,203

Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses

Sui, J., Hwang, W. C., Perez, S., Ge, W., Aird, D. R., Chen, L., Santelli, E., Stec, B., Cadwell, G., Ali, M., et al. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1566 · Cited by 1,128

The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype)

Caton, A. J., Brownlee, G. G., Yewdell, J. W., & Gerhard, W. (1982) · Cell · doi:10.1016/0092-8674(82)90135-0 · Cited by 1,036

Rapid cloning of high-affinity human monoclonal antibodies against influenza virus

Wrammert, J., Smith, K., Miller, J., Langley, W. A., Kokko, K. E., Larsen, C. P., Zheng, N., Mays, I., Garman, L., Helms, C., et al. (2008) · Nature · doi:10.1038/nature06890 · Cited by 1,026

Highly Conserved Protective Epitopes on Influenza B Viruses

Dreyfus, C., Laursen, N. S., Kwaks, T., Zuijdgeest, D., Khayat, R., Ekiert, D. C., Lee, J. H., Metlagel, Z., Bujny, M. V., Jongeneelen, M. A. C., et al. (2012) · Science · doi:10.1126/science.1222908 · Cited by 857

Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection

Wrammert, J., Koutsonanos, D., Li, G., Edupuganti, S., Sui, J., Michael, M., McCausland, M. M., Skountzou, I., Hornig, M., Lipkin, W. I., et al. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20101352 · Cited by 777

The human antibody response to influenza A virus infection and vaccination

Krammer, F. (2019) · Nature reviews. Immunology · doi:10.1038/s41577-019-0143-6 · Cited by 819

Advances in the development of influenza virus vaccines

Krammer, F., & Palese, P. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4529 · Cited by 592

Potent protection against H5N1 and H7N9 influenza via childhood hemagglutinin imprinting

Gostic, K. M., Ambrose, M. R., Worobey, M., & Lloyd‐Smith, J. O. (2016) · Science · doi:10.1126/science.aag1322 · Cited by 456

Immune history profoundly affects broadly protective B cell responses to influenza

Andrews, S. F., Huang, Y., Kaur, K., Popova, L. I., Ho, I. Y., Pauli, N. T., Henry, C., Taylor, W. M., Lim, S., Huang, M., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aad0522 · Cited by 413

Restricted Clonality and Limited Germinal Center Reentry Characterize Memory B Cell Reactivation by Boosting

Mesin, L., Schiepers, A., Ersching, J., Barbulescu, A., Cavazzoni, C. B., Angelini, A., Okada, T., Kurosaki, T., & Victora, G. D. (2019) · Cell · doi:10.1016/j.cell.2019.11.032 · Cited by 352

A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial

Nachbagauer, R., Feser, J., Naficy, A. B., Bernstein, D. I., Guptill, J. T., Walter, E. B., Berlanda-Scorza, F., Stadlbauer, D., Wilson, P. C., Aydillo, T., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1118-7 · Cited by 340

Next-generation influenza vaccines: opportunities and challenges

Wei, C., Crank, M. C., Shiver, J. W., Graham, B. S., Mascola, J. R., & Nabel, G. J. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0056-x · Cited by 324

Quadrivalent influenza nanoparticle vaccines induce broad protection

Boyoglu-Barnum, S., Ellis, D., Gillespie, R. A., Hutchinson, G. B., Park, Y., Moin, S. M., Acton, O. J., Ravichandran, R., Murphy, M., Pettie, D., et al. (2021) · Nature · doi:10.1038/s41586-021-03365-x · Cited by 326

Molecular-level analysis of the serum antibody repertoire in young adults before and after seasonal influenza vaccination

Lee, J., Boutz, D. R., Chromikova, V., Joyce, M. G., Vollmers, C., Leung, K., Horton, A. P., DeKosky, B. J., Lee, C., Lavinder, J. J., et al. (2016) · Nature Medicine · doi:10.1038/nm.4224 · Cited by 278

From Original Antigenic Sin to the Universal Influenza Virus Vaccine

Henry, C., Palm, A.-K. E., Krammer, F., & Wilson, P. C. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.08.003 · Cited by 262

Towards a universal influenza vaccine: different approaches for one goal

Sautto, G. A., Kirchenbaum, G. A., & Ross, T. M. (2018) · Virology Journal · doi:10.1186/s12985-017-0918-y · Cited by 202

Original Antigenic Sin: How First Exposure Shapes Lifelong Anti–Influenza Virus Immune Responses

Zhang, A., Stacey, H. D., Mullarkey, C. E., & Miller, M. S. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801149 · Cited by 195

Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus

He, W., Tan, G. S., Mullarkey, C. E., Lee, A. J., Lam, M. M. W., Krammer, F., Henry, C., Wilson, P. C., Ashkar, A. A., Palese, P., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1609316113 · Cited by 180

Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial

Houser, K. V., Chen, G. L., Carter, C., Crank, M. C., Nguyen, T., Florez, M. C. B., Berkowitz, N. M., Mendoza, F. H., Hendel, C. S., Gordon, I. J., et al. (2022) · Nature Medicine · doi:10.1038/s41591-021-01660-8 · Cited by 165

Is a Universal Influenza Virus Vaccine Possible?

Nachbagauer, R., & Palese, P. (2019) · Annual Review of Medicine · doi:10.1146/annurev-med-120617-041310 · Cited by 159

How single mutations affect viral escape from broad and narrow antibodies to H1 influenza hemagglutinin

Doud, M. B., Lee, J. M., & Bloom, J. D. (2018) · Nature Communications · doi:10.1038/s41467-018-03665-3 · Cited by 158

Age Dependence and Isotype Specificity of Influenza Virus Hemagglutinin Stalk-Reactive Antibodies in Humans

Nachbagauer, R., Choi, A., Izikson, R., Cox, M. M. J., Palese, P., & Krammer, F. (2016) · mBio · doi:10.1128/mbio.01996-15 · Cited by 149

Design of Nanoparticulate Group 2 Influenza Virus Hemagglutinin Stem Antigens That Activate Unmutated Ancestor B Cell Receptors of Broadly Neutralizing Antibody Lineages

Corbett, K. S., Moin, S. M., Yassine, H. M., Cagigi, A., Kanekiyo, M., Boyoglu-Barnum, S., Myers, S. I., Tsybovsky, Y., Wheatley, A. K., Schramm, C. A., et al. (2019) · mBio · doi:10.1128/mbio.02810-18 · Cited by 146

A universal influenza virus vaccine candidate confers protection against pandemic H1N1 infection in preclinical ferret studies

Nachbagauer, R., Liu, W., Choi, A., Wohlbold, T. J., Atlas, T., Rajendran, M., Solórzano, A., Scorza, F. B., García‐Sastre, A., Palese, P., et al. (2017) · npj Vaccines · doi:10.1038/s41541-017-0026-4 · Cited by 137

Recall of preexisting cross-reactive B cell memory after Omicron BA.1 breakthrough infection

Kaku, C. I., Bergeron, A. J., Ahlm, C., Normark, J., Sakharkar, M., Forsell, M. N. E., & Walker, L. M. (2022) · Science Immunology · doi:10.1126/sciimmunol.abq3511 · Cited by 135

Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands as Influenza Virus Vaccine Adjuvants Induce Rapid, Sustained, and Broadly Protective Responses

Goff, P. H., Hayashi, T., Martínez‐Gil, L., Corr, M., Crain, B., Yao, S., Cottam, H. B., Chan, M., Ramos, I., Eggink, D., et al. (2015) · Journal of Virology · doi:10.1128/jvi.03337-14 · Cited by 119

Broadly Neutralizing Hemagglutinin Stalk-Specific Antibodies Induce Potent Phagocytosis of Immune Complexes by Neutrophils in an Fc-Dependent Manner

Mullarkey, C. E., Bailey, M. J., Golubeva, D., Tan, G. S., Nachbagauer, R., He, W., Novakowski, K. E., Bowdish, D. M. E., Miller, M. S., & Palese, P. (2016) · mBio · doi:10.1128/mbio.01624-16 · Cited by 117

The aryl hydrocarbon receptor controls cell-fate decisions in B cells

Vaidyanathan, B., Chaudhry, A., Yewdell, W. T., Angeletti, D., Yen, W.-F., Wheatley, A. K., Bradfield, C. A., McDermott, A. B., Yewdell, J. W., Rudensky, A. Y., et al. (2016) · The Journal of Experimental Medicine · doi:10.1084/jem.20160789 · Cited by 116

Multi-epitope Models Explain How Pre-existing Antibodies Affect the Generation of Broadly Protective Responses to Influenza

Zarnitsyna, V. I., Lavine, J. S., Ellebedy, A. H., Ahmed, R., & Antia, R. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005692 · Cited by 105

Subdominance and poor intrinsic immunogenicity limit humoral immunity targeting influenza HA stem

Tan, H., Jegaskanda, S., Juno, J. A., Esterbauer, R., Wong, J., Kelly, H. G., Liu, Y., Tilmanis, D., Hurt, A. C., Yewdell, J. W., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci123366 · Cited by 102

Novel universal influenza virus vaccine approaches

Krammer, F. (2016) · Current Opinion in Virology · doi:10.1016/j.coviro.2016.02.002 · Cited by 99

A TLR7-nanoparticle adjuvant promotes a broad immune response against heterologous strains of influenza and SARS-CoV-2

Yin, Q., Luo, W., Mallajosyula, V. V. A., Yang, B., Guo, J., Xie, J., Sun, M., Verma, R., Li, C., Constantz, C. M., et al. (2023) · Nature Materials · doi:10.1038/s41563-022-01464-2 · Cited by 100

H5N1 Vaccine–Elicited Memory B Cells Are Genetically Constrained by the IGHV Locus in the Recognition of a Neutralizing Epitope in the Hemagglutinin Stem

Wheatley, A. K., Whittle, J. R. R., Lingwood, D., Kanekiyo, M., Yassine, H. M., Steven, S., Narpala, S., Prabhakaran, M. S., Matus‐Nicodemos, R., Bailer, R. T., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402835 · Cited by 98

An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adults

Widge, A. T., Hofstetter, A. R., Houser, K. V., Awan, S. F., Chen, G. L., Florez, M. C. B., Berkowitz, N. M., Mendoza, F. H., Hendel, C. S., Holman, L. A., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.ade4790 · Cited by 97

Induction of broad immunity by thermostabilised vaccines incorporated in dissolvable microneedles using novel fabrication methods

Vrdoljak, A., Allen, E. A., Ferrara, F., Temperton, N. J., Crean, A. M., & Moore, A. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.01.019 · Cited by 95

Polyreactive Broadly Neutralizing B Cells are Selected to Provide Defense Against Pandemic Threat Influenza Viruses

Guthmiller, J. J., Lan, L. Y.-L., Fernández‐Quintero, M. L., Han, J., Utset, H. A., Bitar, D. J., Hamel, N. J., Stovicek, O., Li, L., Tepora, M. E., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.10.005 · Cited by 93

Original Antigenic Sin: How Original? How Sinful?Preprint

Yewdell, J. W., & Santos, J. J. D. S. (2020) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a038786 · Cited by 93

Understanding and Manipulating Viral Immunity: Antibody Immunodominance Enters Center Stage

Angeletti, D., & Yewdell, J. W. (2018) · Trends in Immunology · doi:10.1016/j.it.2018.04.008 · Cited by 92

Germinal Center Selection and the Antibody Response to Influenza

Victora, G. D., & Wilson, P. C. (2015) · Cell · doi:10.1016/j.cell.2015.10.004 · Cited by 91

Heads, stalks and everything else: how can antibodies eradicate influenza as a human disease?

Neu, K. E., Henry, C., & Wilson, P. C. (2016) · Current Opinion in Immunology · doi:10.1016/j.coi.2016.05.012 · Cited by 87

Overcoming Barriers in the Path to a Universal Influenza Virus Vaccine

Coughlan, L., & Palese, P. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.06.016 · Cited by 85

Emerging influenza viruses and the prospect of a universal influenza virus vaccine

Krammer, F. (2015) · Biotechnology Journal · doi:10.1002/biot.201400393 · Cited by 85

Adjuvanted H5N1 influenza vaccine enhances both cross-reactive memory B cell and strain-specific naive B cell responses in humans

Ellebedy, A. H., Nachbagauer, R., Jackson, K., Dai, Y.-N., Han, J., Alsoussi, W. B., Davis, C. W., Stadlbauer, D., Rouphael, N., Chromikova, V., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1906613117 · Cited by 83

Masking of antigenic epitopes by antibodies shapes the humoral immune response to influenza

Zarnitsyna, V. I., Ellebedy, A. H., Davis, C. W., Jacob, J., Ahmed, R., & Antia, R. (2015) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2014.0248 · Cited by 82

Vaccination with soluble headless hemagglutinin protects mice from challenge with divergent influenza viruses

Wohlbold, T. J., Nachbagauer, R., Margine, I., Tan, G. S., Hirsh, A., & Krammer, F. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.05.038 · Cited by 82

First exposure to the pandemic H1N1 virus induced broadly neutralizing antibodies targeting hemagglutinin head epitopes

Guthmiller, J. J., Han, J., Li, L., Freyn, A. W., Liu, S. T. H., Stovicek, O., Stamper, C. T., Dugan, H. L., Tepora, M. E., Utset, H. A., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abg4535 · Cited by 77

An influenza H1 hemagglutinin stem-only immunogen elicits a broadly cross-reactive B cell response in humans

Andrews, S. F., Cominsky, L. Y., Shimberg, G. D., Gillespie, R. A., Gorman, J., Raab, J. E., Brand, J., Creanga, A., Gajjala, S. R., Narpala, S., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.ade4976 · Cited by 77

Antibody modulation of B cell responses—Incorporating positive and negative feedback

Cyster, J. G., & Wilson, P. C. (2024) · Immunity · doi:10.1016/j.immuni.2024.06.009 · Cited by 78

What Lies Beneath: Antibody Dependent Natural Killer Cell Activation by Antibodies to Internal Influenza Virus Proteins

Vanderven, H. A., Ana‐Sosa‐Batiz, F., Jegaskanda, S., Rockman, S. P., Laurie, K., Barr, I., Chen, W., Wines, B. D., Hogarth, P. M., Lambe, T., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.04.029 · Cited by 76

Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for In Vivo Protection in a Serum Transfer Mouse Challenge Model

Jacobsen, H., Rajendran, M., Choi, A., Sjursen, H., Brokstad, K. A., Cox, R. J., Palese, P., Krammer, F., & Nachbagauer, R. (2017) · mBio · doi:10.1128/mbio.01463-17 · Cited by 73

Preexisting subtype immunodominance shapes memory B cell recall response to influenza vaccination

Abreu, R. B., Kirchenbaum, G. A., Clutter, E. F., Sautto, G. A., & Ross, T. M. (2019) · JCI Insight · doi:10.1172/jci.insight.132155 · Cited by 71

Imprinting, immunodominance, and other impediments to generating broad influenza immunity

Knight, M., Changrob, S., Li, L., & Wilson, P. C. (2020) · Immunological Reviews · doi:10.1111/imr.12900 · Cited by 69

Polyclonal epitope mapping reveals temporal dynamics and diversity of human antibody responses to H5N1 vaccination

Han, J., Schmitz, A. J., Richey, S. T., Dai, Y.-N., Turner, H. L., Mohammed, B. M., Fremont, D. H., Ellebedy, A. H., & Ward, A. B. (2021) · Cell Reports · doi:10.1016/j.celrep.2020.108682 · Cited by 61

Harnessing immune history to combat influenza viruses

Guthmiller, J. J., & Wilson, P. C. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.05.010 · Cited by 61

Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies

Bajic, G., van der Poel, C. E., Kuraoka, M., Schmidt, A. G., Carroll, M. C., Kelsoe, G. H., & Harrison, S. C. (2019) · Scientific Reports · doi:10.1038/s41598-019-40175-8 · Cited by 60

How a well-adapting immune system remembers

Mayer, A., Balasubramanian, V., Walczak, A. M., & Mora, T. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1812810116 · Cited by 55

Sequential Immunization With Live-Attenuated Chimeric Hemagglutinin-Based Vaccines Confers Heterosubtypic Immunity Against Influenza A Viruses in a Preclinical Ferret Model

Liu, W., Nachbagauer, R., Stadlbauer, D., Solórzano, A., Scorza, F. B., García‐Sastre, A., Palese, P., Krammer, F., & Albrecht, R. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00756 · Cited by 57

Bringing immunofocusing into focus

Musunuri, S., Weidenbacher, P. A. B., & Kim, P. S. (2024) · npj Vaccines · doi:10.1038/s41541-023-00792-x · Cited by 48

Protein Microarray Analysis of the Specificity and Cross-Reactivity of Influenza Virus Hemagglutinin-Specific Antibodies

Nakajima, R., Supnet, M., Jasinskas, A., Jain, A., Taghavian, O., Obiero, J. M., Milton, D. K., Chen, W. H., Grantham, M. L., Webby, R. J., et al. (2018) · mSphere · doi:10.1128/msphere.00592-18 · Cited by 52

Squalene-Based Influenza Vaccine Adjuvants and Their Impact on the Hemagglutinin-Specific B Cell Response

Nguyen, P. Q. T., Sangster, M. Y., & Topham, D. J. (2021) · Pathogens · doi:10.3390/pathogens10030355 · Cited by 52

B Cell Response to Vaccination

Luo, W., & Yin, Q. (2021) · Immunological Investigations · doi:10.1080/08820139.2021.1903033 · Cited by 55

B Cell Responses against Influenza Viruses: Short-Lived Humoral Immunity against a Life-Long Threat

Guthmiller, J. J., Utset, H. A., & Wilson, P. C. (2021) · Viruses · doi:10.3390/v13060965 · Cited by 56

Broad Hemagglutinin-Specific Memory B Cell Expansion by Seasonal Influenza Virus Infection Reflects Early-Life Imprinting and Adaptation to the Infecting Virus

Tesini, B. L., Kanagaiah, P., Wang, J., Hahn, M. A., Halliley, J. L., Chaves, F. A., Nguyen, P. Q. T., Nogales, A., DeDiego, M. L., Anderson, C., et al. (2019) · Journal of Virology · doi:10.1128/jvi.00169-19 · Cited by 51

Developing Universal Influenza Vaccines: Hitting the Nail, Not Just on the Head

Wiersma, L., Rimmelzwaan, G. F., & de Vries, R. D. (2015) · Vaccines · doi:10.3390/vaccines3020239 · Cited by 48

Immune history shapes human antibody responses to H5N1 influenza viruses

Garretson, T. A., Liu, J., Li, S. H., Scher, G., Santos, J. J. D. S., Hogan, G. E., Vieira, M. C., Furey, C., Atkinson, R. K., Ye, N., et al. (2025) · Nature Medicine · doi:10.1038/s41591-025-03599-6 · Cited by 48

Seasonality in risk of pandemic influenza emergence

Fox, S. J., Miller, J. C., & Ancel, L. W. (2017) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1005749 · Cited by 47

High-Affinity H7 Head and Stalk Domain–Specific Antibody Responses to an Inactivated Influenza H7N7 Vaccine After Priming With Live Attenuated Influenza Vaccine

Halliley, J. L., Khurana, S., Krammer, F., Fitzgerald, T. F., Coyle, E. M., Chung, K. Y., Baker, S. F., Yang, H., Martínez‐Sobrido, L., Treanor, J. J., et al. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv210 · Cited by 45

Implications of broadly neutralizing antibodies in the development of a universal influenza vaccine

Cho, A., & Wrammert, J. (2016) · Current Opinion in Virology · doi:10.1016/j.coviro.2016.03.002 · Cited by 45

Pandemic Paradox: Early Life H2N2 Pandemic Influenza Infection Enhanced Susceptibility to Death during the 2009 H1N1 Pandemic

Gagnon, A., Acosta, E., Hallman, S., Bourbeau, R. R., Dillon, L., Ouellette, N., Earn, D. J. D., Herring, D. A., Inwood, K. E., Madrenas, J., et al. (2018) · mBio · doi:10.1128/mbio.02091-17 · Cited by 45

Requirement for memory B-cell activation in protection from heterologous influenza virus reinfection

Leach, S., Shinnakasu, R., Adachi, Y., Momota, M., Makino‐Okamura, C., Yamamoto, T., Ishii, K. J., Fukuyama, H., Takahashi, Y., & Kurosaki, T. (2019) · International Immunology · doi:10.1093/intimm/dxz049 · Cited by 45

Controlled Human Infection Models To Accelerate Vaccine Development

Choy, R. K. M., Bourgeois, A. L., Ockenhouse, C. F., Walker, R. I., Sheets, R., & Flores, J. (2022) · Clinical Microbiology Reviews · doi:10.1128/cmr.00008-21 · Cited by 48

Sequential Infection in Ferrets with Antigenically Distinct Seasonal H1N1 Influenza Viruses Boosts Hemagglutinin Stalk-Specific Antibodies

Kirchenbaum, G. A., Carter, D. M., & Ross, T. M. (2015) · Journal of Virology · doi:10.1128/jvi.02372-15 · Cited by 44

A single residue in influenza virus H2 hemagglutinin enhances the breadth of the B cell response elicited by H2 vaccination

Andrews, S. F., Raab, J. E., Gorman, J., Gillespie, R. A., Cheung, C. S. F., Rawi, R., Cominsky, L. Y., Boyington, J. C., Creanga, A., Shen, C., et al. (2022) · Nature Medicine · doi:10.1038/s41591-021-01636-8 · Cited by 43

Next-Generation Influenza VaccinesPreprint

Kanekiyo, M., & Graham, B. S. (2020) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a038448 · Cited by 40

Strategies to induce broadly protective antibody responses to viral glycoproteins

Krammer, F. (2017) · Expert Review of Vaccines · doi:10.1080/14760584.2017.1299576 · Cited by 41

Vaccination with a Recombinant H7 Hemagglutinin-Based Influenza Virus Vaccine Induces Broadly Reactive Antibodies in Humans

Stadlbauer, D., Rajabhathor, A., Amanat, F., Kaplan, D., Masud, A., Treanor, J. J., Izikson, R., Cox, M. M. J., Nachbagauer, R., & Krammer, F. (2017) · mSphere · doi:10.1128/msphere.00502-17 · Cited by 41

Influenza Virus Like Particles (VLPs): Opportunities for H7N9 Vaccine Development

Pushko, P., & Tretyakova, I. (2020) · Viruses · doi:10.3390/v12050518 · Cited by 40

Vaccination with Vesicular Stomatitis Virus-Vectored Chimeric Hemagglutinins Protects Mice against Divergent Influenza Virus Challenge Strains

Ryder, A. B., Nachbagauer, R., Buonocore, L., Palese, P., Krammer, F., & Rose, J. K. (2015) · Journal of Virology · doi:10.1128/jvi.02598-15 · Cited by 39

Development of next generation hemagglutinin-based broadly protective influenza virus vaccines

Nachbagauer, R., & Palese, P. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.04.001 · Cited by 39

Broadly protective anti-hemagglutinin stalk antibodies induced by live attenuated influenza vaccine expressing chimeric hemagglutinin

Николаевна, И.-С. И., Korenkov, D. A., Smolonogina, T. A., Kotomina, T. S., Donina, S., Matyushenko, V., Mezhenskaya, D. А., Krammer, F., & Георгиевна, Р. Л. (2018) · Virology · doi:10.1016/j.virol.2018.03.013 · Cited by 38

Broadly Reactive Human Monoclonal Antibodies Elicited following Pandemic H1N1 Influenza Virus Exposure Protect Mice against Highly Pathogenic H5N1 Challenge

Nachbagauer, R., Shore, D. A., Yang, H., Johnson, S. K., Gabbard, J. D., Tompkins, S. M., Wrammert, J., Wilson, P. C., Stevens, J., Ahmed, R., et al. (2018) · Journal of Virology · doi:10.1128/jvi.00949-18 · Cited by 38

T and B Cell Immune Responses to Influenza Viruses in Pigs

Holzer, B., Martini, V., Edmans, M. D., & Tchilian, E. Z. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00098 · Cited by 38

The Role of Pre-existing Cross-Reactive Central Memory CD4 T-Cells in Vaccination With Previously Unseen Influenza Strains

Nienen, M., Stervbo, U., Mölder, F., Kaliszczyk, S., Kuchenbecker, L., Gayova, L., Schweiger, B., Jürchott, K., Hecht, J., Neumann, A. U., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00593 · Cited by 36

Measuring the neutralization potency of influenza A virus hemagglutinin stalk/stem-binding antibodies in polyclonal preparations by microneutralization assay

He, W., Mullarkey, C. E., & Miller, M. S. (2015) · Methods · doi:10.1016/j.ymeth.2015.04.037 · Cited by 35

Inactivated influenza virus vaccines: the future of TIV and QIV

Schotsaert, M., & García‐Sastre, A. (2017) · Current Opinion in Virology · doi:10.1016/j.coviro.2017.04.005 · Cited by 33

Pre-existing heterosubtypic immunity provides a barrier to airborne transmission of influenza viruses

Sage, V. L., Jones, J. E., Kormuth, K. A., Fitzsimmons, W. J., Nturibi, E. M., Padovani, G. H., Arevalo, C. P., French, A. J., Avery, A. J., Manivanh, R. V., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009273 · Cited by 34

Vaccination against rapidly evolving pathogens and the entanglements of memory

Cobey, S. E. (2024) · Nature Immunology · doi:10.1038/s41590-024-01970-2 · Cited by 39

Multi-Dimensional Measurement of Antibody-Mediated Heterosubtypic Immunity to Influenza

Wang, J., Hilchey, S. P., Hyrien, O., Huertas, N., Perry, S., Manojkumar, R., Bucher, D. J., & Zand, M. S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129858 · Cited by 32

Influenza H7N9 LAH-HBc virus-like particle vaccine with adjuvant protects mice against homologous and heterologous influenza viruses

Zheng, D., Chen, S., Qu, D., Chen, J., Wang, F., Zhang, R., & Chen, Z. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.11.026 · Cited by 32

Adeno‐associated virus‐vectored influenza vaccine elicits neutralizing and Fcγ receptor‐activating antibodies

Demminger, D. E., Walz, L., Dietert, K., Hoffmann, H., Planz, O., Gruber, A. D., von Messling, V., & Wolff, T. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.201910938 · Cited by 32

The Next Generation of Influenza Vaccines: Towards a Universal Solution

McMillan, C. L. D., Young, P. R., Watterson, D., & Chappell, K. J. (2021) · Vaccines · doi:10.3390/vaccines9010026 · Cited by 34

Elicitation of broadly protective immunity to influenza by multivalent hemagglutinin nanoparticle vaccinesPreprint

Boyoglu-Barnum, S., Ellis, D., Gillespie, R. A., Hutchinson, G. B., Park, Y., Moin, S. M., Acton, O. J., Ravichandran, R., Murphy, M., Pettie, D., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.30.125179 · Cited by 32

Characterising antibody kinetics from multiple influenza infection and vaccination events in ferrets

Hay, J. A., Laurie, K., White, M. T., & Riley, S. (2019) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1007294 · Cited by 29

Influenza virus antigenicity and broadly neutralizing epitopes

Air, G. M. (2015) · Current Opinion in Virology · doi:10.1016/j.coviro.2015.03.006 · Cited by 30

A Novel Synthetic Dual Agonistic Liposomal TLR4/7 Adjuvant Promotes Broad Immune Responses in an Influenza Vaccine With Minimal Reactogenicity

Sato-Kaneko, F., Yao, S., Lao, F. S., Shpigelman, J., Messer, K. S., Pu, M., Shukla, N. M., Cottam, H. B., Chan, M. D., Chu, P. J., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01207 · Cited by 30

Antibody Focusing to Conserved Sites of Vulnerability: The Immunological Pathways for ‘Universal’ Influenza Vaccines

Sangesland, M., & Lingwood, D. (2021) · Vaccines · doi:10.3390/vaccines9020125 · Cited by 34

Early influenza virus exposure shapes the B cell response to influenza vaccination in individuals 50 years later

Spangler, A., Shimberg, G. D., Mantus, G. E., Malek, R., Cominsky, L. Y., Tsybovsky, Y., Li, N., Gillespie, R. A., Ravichandran, M., Creanga, A., et al. (2025) · Immunity · doi:10.1016/j.immuni.2025.02.004 · Cited by 29

Mini-HA Is Superior to Full Length Hemagglutinin Immunization in Inducing Stem-Specific Antibodies and Protection Against Group 1 Influenza Virus Challenges in Mice

van der Lubbe, J. E. M., Verspuij, J. W. A., Huizingh, J., Schmit-Tillemans, S. P. R., Tolboom, J. T. B. M., Dekking, L., Kwaks, T., Brandenburg, B., Meijberg, W., Zahn, R. C., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02350 · Cited by 29

Recombinant Influenza Vaccines: Saviors to Overcome Immunodominance

Mathew, N. R., & Angeletti, D. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02997 · Cited by 29

Infection of Ferrets with Influenza Virus Elicits a Light Chain–Biased Antibody Response against Hemagglutinin

Kirchenbaum, G. A., Allen, J. D., Layman, T. S., Sautto, G. A., & Ross, T. M. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1701174 · Cited by 28

Pandemic influenza virus vaccines boost hemagglutinin stalk-specific antibody responses in primed adult and pediatric cohorts

Nachbagauer, R., Salaun, B., Stadlbauer, D., Behzadi, M. A., Friel, D., Rajabhathor, A., Choi, A., Albrecht, R. A., Debois, M., García‐Sastre, A., et al. (2019) · npj Vaccines · doi:10.1038/s41541-019-0147-z · Cited by 28

The antibody landscapes following AS03 and MF59 adjuvanted H5N1 vaccination

Goll, J. B., Jain, A., Jensen, T. L., de Assis, R., Nakajima, R., Jasinskas, A., Coughlan, L., Cherikh, S. R., Gelber, C. E., Khan, S., et al. (2022) · npj Vaccines · doi:10.1038/s41541-022-00524-7 · Cited by 28

A multicolour HLA-specific B-cell FluoroSpot assay to functionally track circulating HLA-specific memory B cells

Luque, S., Lúcia, M., Crespo, E., Jarque, M., Grinyo, J. M., & Bestard, O. (2018) · Journal of Immunological Methods · doi:10.1016/j.jim.2018.07.011 · Cited by 28

Administration of Multivalent Influenza Virus Recombinant Hemagglutinin Vaccine in Combination-Adjuvant Elicits Broad Reactivity Beyond the Vaccine Components

Hernandez‐Davies, J. E., Felgner, J. H., Strohmeier, S., Pone, E. J., Jain, A., Jan, S., Nakajima, R., Jasinskas, A., Strahsburger, E., Krammer, F., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.692151 · Cited by 26

Inducing broad-based immunity against viruses with pandemic potential

Sette, A., & Saphire, E. O. (2022) · Immunity · doi:10.1016/j.immuni.2022.04.010 · Cited by 25

Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells

Li, G.-M., Chiu, C., Wrammert, J., McCausland, M. M., Andrews, S. F., Zheng, N., Lee, J.-H., Huang, M., Qu, X., Edupuganti, S., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1118979109 · Cited by 393

Induction of Broadly Neutralizing H1N1 Influenza Antibodies by Vaccination

Wei, C., Boyington, J. C., McTamney, P. M., Kong, W., Pearce, M. B., Xu, L., Andersen, H., Rao, S. S., Tumpey, T. M., Yang, Z., et al. (2010) · Science · doi:10.1126/science.1192517 · Cited by 337

A single residue in influenza virus H2 hemagglutinin enhances the breadth of the B cell response elicited by H2 vaccination

Andrews, S. F., Raab, J. E., Gorman, J., Gillespie, R. A., Cheung, C. S. F., Rawi, R., Cominsky, L. Y., Boyington, J. C., Creanga, A., Shen, C., et al. (2022) · Nature Medicine · doi:10.1038/s41591-021-01636-8 · Cited by 43

An influenza H1 hemagglutinin stem-only immunogen elicits a broadly cross-reactive B cell response in humans

Andrews, S. F., Cominsky, L. Y., Shimberg, G. D., Gillespie, R. A., Gorman, J., Raab, J. E., Brand, J., Creanga, A., Gajjala, S. R., Narpala, S., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.ade4976 · Cited by 77

Pandemic H1N1 Influenza Infection and Vaccination in Humans Induces Cross-Protective Antibodies that Target the Hemagglutinin Stem

Thomson, C. A., Wang, Y., Jackson, L. M., Olson, M., Wang, W., Liavonchanka, A., Keleta, L., da Silva, V. G. L., Diederich, S., Jones, R. B., et al. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00087 · Cited by 109